Skip to main content
. 2013 Dec 3;14(12):23639–23653. doi: 10.3390/ijms141223639

Figure 4.

Figure 4.

TGA of (A) iron oxide nanoparticles; (B) perindopril erbumine; and (C) iron oxide nanoparticles coated with chitosan-perindopril erbumine (FCPE).